The food we love does not always receive the same appreciation from our digestive tract and can be the leading cause of GI discomfort. Imagine being able to seamlessly assimilate the most challenging protein for your gut while transforming it into super-food simply by sprinkling a dash of specialized enzyme like you would season your favorite dish. This is how Amplifye innovates.
Using computational modeling and AI-powered technology, Amplifye, a biotech company catalyzed by IIFH, is developing a broad range of proteases (enzymes that break down proteins) to improve food digestibility and unlock the full health potential of dietary proteins. Designed with high specificity and efficiency, Amplifye’s proprietary enzymes maximize the nutritional value of our food by improving protein absorption and quality. This IIFH-enabled technology takes nutrition and global health to the next level. By creating unique connections between food and engineered enzymes, the startup offers an unprecedented opportunity to modulate the release of specific bioactive peptides that affect our health and well-being. From metabolic and cognitive health to inflammatory disease mitigation and healthy aging, the applications are virtually endless. In addition to its impact on individual health, this technology provides a valuable solution to nutritional challenges in undernourished communities by improving the digestibility of suboptimal protein sources. Co-founded by Justin Siegel, Faculty Director of IIFH, and Wilson Mak, a former graduate student in Siegel’s lab and now Chief Technology Officer at Amplifye, the startup has received venture funding from The March Group (TMG) and Astanor.
